| ACFs | Activated charcoal filters |
| Ca2+ | Calcium |
| CCD | Central core disease |
| CHCT | Caffeine/halothane contracture test |
| DHPR | Dihydropyridine receptor |
| EMHG | European Malignant Hyperthermia Group |
| ETCO2 | End-tidal carbon dioxide |
| GA | General anesthesia |
| HypoPP | Hypokalemic periodic paralysis |
| IVCT | In vitro contracture test |
| MELAS | Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes |
| MH | Malignant hyperthermia |
| MHANZ | Malignant Hyperthermia Group of Australia and New Zealand |
| MHAUS | Malignant Hyperthermia Association of the United States |
| MHS | Malignant hyperthermia susceptibility |
| MmD | Multi-mini core disease |
| MMR | Masseter muscle rigidity |
| PICU | Pediatric intensive care unit |
| RyR1 | Type 1 ryanodine receptor |
| SERCA | Sarcoendoplasmic reticulum calcium ATPase |
| SR | Sarcoplasmic reticulum |
| TIVA | Total intravenous anesthesia |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.